Skip to main content

Greensboro Firm Inks Deal to Bring Smartphone-Based Fertility Test to Animal Breeding

The Scullion Strategy Group, based in Greensboro, has inked an exclusive option agreement with Boston-based Brigham and Women’s Hospital (BWH) to license patent rights in semen analysis for veterinary use.

TransEnterix Gains FDA Approval for Surgical Robotic System

Morrisville-based TransEnterix has received clearance from the U.S. Food and Drug Administration to begin selling its Senhance surgical robotic system.

NCBiotech Event Planted RTP Seed for High-Tech Tree Startup

An appearance at a North Carolina Biotechnology Center event in 2016 convinced the CEO of a high-tech ag biotech startup to move his company from Massachusetts to the Research Triangle.

BASF Buying Bayer Crop Science Assets for $7B, Including Employees, Buildings

German conglomerate Bayer AG has agreed to sell crop science businesses for $7 billion to BASF, including its R&D employees and campus in the Research Triangle Park.

Biotech Roundtable to Examine Legal, Ethical, Regulatory Issues in Ag

New genetic editing tools raise a host of ethical, legal, and regulatory questions in agricultural biotechnology innovation. That is the topic scientists, legal experts, and industry executives will tackle at an unusual event at the North Carolina Biotechnology Center Oct. 24.

RTP Nonprofit MEDIC Launches Fundraising Campaign

The Medical Innovators Collaborative (MEDIC) has launched its first fundraising campaign to support its work as a medical device hub in the Research Triangle Park.

Spanish Company Chooses NC for North American Headquarters

PlantResponse, a plant biotechnology company based in Madrid, has established its North American headquarters in North Carolina’s Research Triangle Park and is looking for permanent facilities in the area.

Heat Bio’s Pelican Subsidiary Strikes Deal with Selexis to Advance Cancer Immunotherapy

Pelican Therapeutics, a subsidiary of Durham-based Heat Biologics Inc., has entered a service agreement with Geneva-based Selexis SA to advance development of Pelican’s cancer-fighting therapy candidates.

Sumitomo Invests in Piedmont Animal Health

Greensboro-based Piedmont Animal Health, a developer of health products for companion animals, has gained a strategic equity investment from the life science division of Sumitomo Corp., a Fortune 500 company based in Tokyo.

Fennec Pharma Taking the Lead in Reducing Pediatric Chemo Hearing Loss

Fennec Pharmaceuticals, a specialty pharmaceutical company with executive headquarters in the Research Triangle Park, is making a difference for children with hearing loss.


Subscribe to RSS - Life Sciences